Concepedia

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

John B. Buse, David C. Klonoff, Loretta L. Nielsen, Xuesong Guan, Christopher L. Bowlus, John H. Holcombe, David Maggs, Matthew Wintle

Clinical Therapeutics · 2007 · 280 citations · 31 references

DOI

Concepts

References

31

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

David R. Matthews, J P Hosker, A. Rudenski et al. · Diabetologia · 1985 · 31.4K citations · Full text

, , +17

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

The Lancet · 1998 · 20.1K citations

, , +13

Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001

Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman et al. · JAMA · 2003 · 5.9K citations

, , +7

World Medical Association Declaration of Helsinki

Not Available Not Available · JAMA · 2000 · 2.4K citations

, , +2

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han et al. · Diabetes Care · 2005 · 1.6K citations

, , +11